Ignite Creation Date:
2024-05-06 @ 6:45 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05775432
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2023-02-14
Brief Title:
Prognosis of Heart Transplanted Patients With Heart Failure
Sponsor:
First Affiliated Hospital Xian Jiaotong University
Organization:
First Affiliated Hospital Xian Jiaotong University
Study Overview
Official Title:
Prognosis of Heart Transplanted Patients With Heart Failure RE-START a National Multi-center Retrospective-prospective Cohort Study
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RE-START
Brief Summary:
Heart transplantation is the most effective treatment for end-stage heart failure advanced cardiomyopathy and complex congenital heart disease with severe heart failure or hypoxia Several clinical studies have shown significant differences in the prognosis of heart transplantation patients with different etiologies and post-transplantation complications are an important factor affecting patient survival and there is still a lack of overall prognostic stratification and extensive clinical studies on risk factors after heart transplantation Therefore this study is intended to include patients who underwent heart transplantation for different etiologies of heart failure collect clinical data and biological samples from patients and use various techniques to deeply interpret the risk factors affecting the prognosis of heart transplantation patients and construct a prognostic prediction model to provide specific and individualized treatment ideas and theoretical basis for improving the survival rate of patients after heart transplantation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None